|
Volumn 13, Issue 3, 2001, Pages 191-192
|
Rheumatoid arthritis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ETANERCEPT;
INFLIXIMAB;
METHOTREXATE;
OSTEOPROTEGERIN;
STROMAL CELL DERIVED FACTOR 1;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
CELL ACTIVATION;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG EFFICACY;
DRUG SAFETY;
EDITORIAL;
FIBROBLAST;
HUMAN;
OSTEOLYSIS;
PATHOGENESIS;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
T LYMPHOCYTE;
ANTIRHEUMATIC AGENTS;
ARTHRITIS, RHEUMATOID;
CYTOKINES;
HUMANS;
SIGNAL TRANSDUCTION;
|
EID: 0035021662
PISSN: 10408711
EISSN: None
Source Type: Journal
DOI: 10.1097/00002281-200105000-00007 Document Type: Editorial |
Times cited : (9)
|
References (9)
|